HIV Articles
Back
	ENLICITIDE DECANOATE, AN ORAL PCSK9 INHIBITOR, IN PARTICIPANTS WITH HETEROZVYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: A DOUBLE-BLIND, PHASE 3, RANDOMIZED PLACEBO-CONTROLLED TRIAL       AHA Nov 7-10 New Orleans   Efficacy and Safety of Enlicitide, an oral PCSK9 Inhibitor, For Lowering LDL Cholesterol in Adults with or At Risk for ASCVD: The Phase 3 CORALREEF Lipids Trial - (11/13/25)           View Older Articles   Back to Top   www.natap.org